These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19741261)

  • 21. [Cigarette smoking is the most important causal factor for developing chronic obstructive pulmonary disease (COPD)].
    Muro S
    Nihon Rinsho; 2011 Oct; 69(10):1735-40. PubMed ID: 22073565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation.
    Soriano JB; Rodríguez-Roisin R
    Proc Am Thorac Soc; 2011 Aug; 8(4):363-7. PubMed ID: 21816993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis.
    Eden E
    COPD; 2010 Oct; 7(5):366-74. PubMed ID: 20854052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The aging lung and chronic obstructive pulmonary disease: similarity and difference.
    Fukuchi Y
    Proc Am Thorac Soc; 2009 Dec; 6(7):570-2. PubMed ID: 19934351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.
    Slama K
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):3-7. PubMed ID: 18173869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking-related diseases: the importance of COPD.
    Zaher C; Halbert R; Dubois R; George D; Nonikov D
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1423-8. PubMed ID: 15636487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models of chronic obstructive pulmonary disease.
    Szelenyi I; Marx D
    Arzneimittelforschung; 2001; 51(12):1004-14. PubMed ID: 11799838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possible correlations between periodontitis and chronic obstructive pulmonary disease. Review of the literature].
    Martos R; Márton I
    Fogorv Sz; 2011 Sep; 104(3):87-92. PubMed ID: 22039714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging drugs for alpha-1-antitrypsin deficiency.
    Stockley RA
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):685-94. PubMed ID: 20716026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden.
    Hemminki K; Li X; Sundquist K; Sundquist J
    J Epidemiol Community Health; 2008 May; 62(5):398-401. PubMed ID: 18413451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current aspects in etiopathogenesis and diagnosis of chronic obstructive pulmonary disease.
    Leru P
    Rom J Intern Med; 2004; 42(1):83-93. PubMed ID: 15529597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial predisposition to chronic obstructive pulmonary disease].
    Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 2009; 77(4):407-10. PubMed ID: 19722147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic obstructive pulmonary disease and cardiovascular diseases].
    Passowicz-Muszyńska E; Gostkowska-Malec A; Jankowska R; Piesiak P
    Pneumonol Alergol Pol; 2010; 78(1):28-32. PubMed ID: 20162516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which pulmonary function tests best differentiate between COPD phenotypes?
    Salzman SH
    Respir Care; 2012 Jan; 57(1):50-57; discussion 58-60. PubMed ID: 22222125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II)].
    Szulakowski P; Mróz RM; Pierzchała W; Chyczewska E; MacNee W
    Wiad Lek; 2006; 59(3-4):250-4. PubMed ID: 16813274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and global impact of chronic obstructive pulmonary disease.
    Mannino DM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.